中药抗难愈性创面耐甲氧西林金黄色葡萄球菌研究进展  

Traditional Chinese medicine against refractory ethicillin resistant Staphylococcus aureus in wound infection: research progress

作　　者：倪俊[1] 许献荣[1] 

机构地区：[1]中国人民解放军第八五医院烧伤整形外科,上海200052

出　　处：《中国微生态学杂志》2015年第9期1105-1110,共6页Chinese Journal of Microecology

基　　金：上海市中医药科研基金课题(2014LP033A)

摘　　要：难愈性创面耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus,MRSA)具有多重耐药性、对消毒剂抗性和形成细菌生物膜等特点。有效针对难愈性创面MRSA的中药应具有抗MRSA和生物膜的能力。本文就近年来的相关研究进展进行了综述。The refractory methicillin-resistant Staphylococcus aureus（ MRSA） in wound infection has multi-drug resistance,disinfectant resistance and the ability to develop biofilm. Effective traditional Chinese medicines against refractory wound MRSAs should have anti-MRSA and anti-biofilm activity. In this review,the progress in the researches on those was particularly discussed.

关 键 词：耐药性创面 金黄色葡萄球菌 甲氧西林 中药 生物膜 

分 类 号：R378.11[医药卫生—病原生物学]